Literature DB >> 26358009

Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries.

Margaret E Olson1, Daniel Abate-Pella1, Angela L Perkins1, Ming Li1, Michael A Carpenter1, Anurag Rathore1, Reuben S Harris1, Daniel A Harki1.   

Abstract

High-throughput screening (HTS) was employed to discover APOBEC3G inhibitors, and multiple 2-furylquinolines (e.g., 1) were found. Dose-response assays with 1 from the HTS sample, as well as commercial material, yielded similar confirmatory results. Interestingly, freshly synthesized and DMSO-solubilized 1 was inactive. Repeated screening of the DMSO aliquot of synthesized 1 revealed increasing APOBEC3G inhibitory activity with age, suggesting that 1 decomposes into an active inhibitor. Laboratory aging of 1 followed by analysis revealed that 1 undergoes oxidative decomposition in air, resulting from a [4 + 2] cycloaddition between the furan of 1 and (1)O2. The resulting endoperoxide then undergoes additional transformations, highlighted by Baeyer-Villager rearrangements, to deliver lactam, carboxylic acid, and aldehyde products. The endoperoxide also undergoes hydrolytic opening followed by further transformations to a bis-enone. Eight structurally related analogues from HTS libraries were similarly reactive. This study constitutes a cautionary tale to validate 2-furylquinolines for structure and stability prior to chemical optimization campaigns.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26358009      PMCID: PMC4610730          DOI: 10.1021/acs.jmedchem.5b00930

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  36 in total

1.  The effect of room-temperature storage on the stability of compounds in DMSO.

Authors:  Barbara A Kozikowski; Thomas M Burt; Debra A Tirey; Lisa E Williams; Barbara R Kuzmak; David T Stanton; Kenneth L Morand; Sandra L Nelson
Journal:  J Biomol Screen       Date:  2003-04

2.  Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists.

Authors:  Neelu Kaila; Kristin Janz; Silvano DeBernardo; Patricia W Bedard; Raymond T Camphausen; Steve Tam; Desirée H H Tsao; James C Keith; Cheryl Nickerson-Nutter; Adam Shilling; Ruth Young-Sciame; Qin Wang
Journal:  J Med Chem       Date:  2007-01-11       Impact factor: 7.446

3.  A high-throughput screen for aggregation-based inhibition in a large compound library.

Authors:  Brian Y Feng; Anton Simeonov; Ajit Jadhav; Kerim Babaoglu; James Inglese; Brian K Shoichet; Christopher P Austin
Journal:  J Med Chem       Date:  2007-04-21       Impact factor: 7.446

4.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

5.  Identification of a New Series of STAT3 Inhibitors by Virtual Screening.

Authors:  Kenji Matsuno; Yoshiaki Masuda; Yutaka Uehara; Hiroshi Sato; Ayumu Muroya; Osamu Takahashi; Takane Yokotagawa; Toshio Furuya; Tadashi Okawara; Masami Otsuka; Naohisa Ogo; Tadashi Ashizawa; Chie Oshita; Sachiko Tai; Hidee Ishii; Yasuto Akiyama; Akira Asai
Journal:  ACS Med Chem Lett       Date:  2010-07-13       Impact factor: 4.345

6.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

7.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

Review 8.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Authors:  John S Albin; Reuben S Harris
Journal:  Expert Rev Mol Med       Date:  2010-01-22       Impact factor: 5.600

9.  Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments.

Authors:  Karina M Soares; Nicole Blackmon; Tong Ying Shun; Sunita N Shinde; Harold K Takyi; Peter Wipf; John S Lazo; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

10.  PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.

Authors:  Jayme L Dahlin; J Willem M Nissink; Jessica M Strasser; Subhashree Francis; LeeAnn Higgins; Hui Zhou; Zhiguo Zhang; Michael A Walters
Journal:  J Med Chem       Date:  2015-02-21       Impact factor: 8.039

View more
  8 in total

Review 1.  Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials.

Authors:  Joseph B O'Brien; Joshua C Wilkinson; David L Roman
Journal:  J Biol Chem       Date:  2019-10-21       Impact factor: 5.157

2.  Discovery of Small-Molecule Inhibitors Targeting the E3 Ubiquitin Ligase Activity of the Herpes Simplex Virus 1 ICP0 Protein Using an In Vitro High-Throughput Screening Assay.

Authors:  Thibaut Deschamps; Hope Waisner; Christos Dogrammatzis; Anuradha Roy; Shibin Chacko; Chamani Perera; Thomas E Prisinzano; Maria Kalamvoki
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

Review 3.  APOBEC Enzymes as Targets for Virus and Cancer Therapy.

Authors:  Margaret E Olson; Reuben S Harris; Daniel A Harki
Journal:  Cell Chem Biol       Date:  2017-11-16       Impact factor: 8.116

Review 4.  Nuisance compounds in cellular assays.

Authors:  Jayme L Dahlin; Douglas S Auld; Ina Rothenaigner; Steve Haney; Jonathan Z Sexton; J Willem M Nissink; Jarrod Walsh; Jonathan A Lee; John M Strelow; Francis S Willard; Lori Ferrins; Jonathan B Baell; Michael A Walters; Bruce K Hua; Kamyar Hadian; Bridget K Wagner
Journal:  Cell Chem Biol       Date:  2021-02-15       Impact factor: 8.116

5.  Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds.

Authors:  Matthew K Matlock; Tyler B Hughes; Jayme L Dahlin; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2018-07-23       Impact factor: 6.162

6.  Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures.

Authors:  Christopher R Bodle; Josephine H Schamp; Joseph B O'Brien; Michael P Hayes; Meng Wu; Jonathan A Doorn; David L Roman
Journal:  SLAS Discov       Date:  2018-01-19       Impact factor: 3.341

7.  Fragment-Based Nuclear Magnetic Resonance Screen against a Regulator of G Protein Signaling Identifies a Binding "Hot Spot".

Authors:  Michael P Hayes; Joseph B O'Brien; Rachel A Crawford; C Andrew Fowler; Liping Yu; Jonathan A Doorn; David L Roman
Journal:  Chembiochem       Date:  2021-02-16       Impact factor: 3.461

Review 8.  Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.

Authors:  S Venkatesan; R Rosenthal; N Kanu; N McGranahan; J Bartek; S A Quezada; J Hare; R S Harris; C Swanton
Journal:  Ann Oncol       Date:  2018-03-01       Impact factor: 32.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.